Szemészet, 2010 (147. évfolyam, 1-4. szám)

2010-12-01 / 3-4. szám

147. évfolyam (2010)

125

6. Christen W.G., Glynn R.J., Manson J.E., Ajani U.A., Buring J.E.: A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996; 276: 1147-1151.

7. Evans W, Wormald R.: Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996; 80: 9-14.

8. Eye Disease Case-Control Study Group: Risk Factors for Neovascular Age Related Macular Degeneration. Arch Ophthalmol 1992; 110: 1701-1708.

9. Ferris F.L. 3rd, Fine, S.L., Flyman L.: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102: 1640-1642.

10. Gold B., Merriam J.E., ZernantJ. et al.: Variation in factor В (CFB) and complement component 2 (CC2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-462.

11. Gorin M.B., Breitner J.C., De Jong P.T., Hageman G.S., Klaver C.C., Kuehn M.H., Seddon J.M.: The genetics of age-related macular degeneration. Mol Vis 1999; 3: 29.

12. Green W.R.: Histopathology of age-related macular degeneration. Mol Vis 1999; 5: 27.

13. Grossniklaus H.E., Green W.R.: Choroidal neovascularization. Am J Ophthalmol 2004; 137: 496-503.

14. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber

A. J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I.., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zemant J., Merriam J.E., Gold

B. , Dean M., Allikmets R.: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005; 102: 7227-7232.

15. Klaver C.C., Wolfs R.C., Vingerling J.R., Hofman A., de Jong P.T.: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653-658.

16. Klein R.: Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 2007; 14: 184-187.

17. Klein R., Klein B.E., Linton K.L.: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943.

18. Klein R., Peto T, Bird A., Vannewkirk M.R.: The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-495.

19. Klein R., Wang Q., Klein B.E. Moss S.E., Meuer S.M.: The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sei 1995; 36: 182-191.

20. Lang Y, Lang N., Ben-Ami M., Garzozi H.: The effects of hormone replacement therapy (HRT) on the human eye. Harefuah 2002; 141: 287-291.

21. Leibowitz H.M., Krueger D.E., Maunder L.R., Milton R.C., Kini M.M., Kahn H.A., Nickerson R.J., Pool J., Colton T.L., Ganley J.P, Loewenstein J.I., Dawber T.R.: The Framingham Eye Study Monograph. Surv Ophthalmol 1980; 24: 335-610.

22. Sackett C.S., Schenning S.: The age-related eye disease study: the results of the clinical trial. Insight. 2002 Jan-Mar; 27: 5-7. PMID: 11962062

23. Seddon, J.M., Ajani, U.A., Sperduto, R.D. et al.: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-1420.

24. Seddon J.M., Willett W.C., SpeizerF.E. Hankinson S.E.: A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 1141-1146.

25. Smith W, MitchellP, LeederS.R., WangJ.J.: Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 583-587.

26. Smith W, Mitchell P, Wang J.J.: Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997; 25: 13-15.

27. WangJ.J., Foran S., Mitchell P: Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2000; 28: 268-273.

28. Winkler B.S., Boulton M.E., Gotisch J.D., Sternberg P: Oxidative damage and age-related macular degeneration. Mol Vis 1999; 3: 32.

29. Yates J.R., MooreA.T.: Genetic susceptibility to age related macular degeneration. J Med Genet 2000; 37: 83-87.

Levelezési cím: Ferenc B. Sallo Moorfields Eye Hospital 162 City Road, EC1V 2PD, London, UK E-mail: ferenc.sallo@moorfields.nhs.uk

Az IDŐSKORI MACULADEGENERÁCIÓ ETIOLÓGIÁJA